Macao vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)
Macao
100.0%
in 2024
Togo
100.0%
in 2024
Macao rank
1st
Togo rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Macao
- Togo
How they compare
Macao currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2008 it was Macao ahead.
Macao ranks 1st and Togo ranks 1st of 144 countries.
Across the 3 decades both report, Macao averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Macao | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 30.0% | 70.0% | Macao |
| 2010s | 65.3% | 84.1% | 18.8% | Togo |
| 2020s | 78.4% | 99.2% | 20.8% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Macao or Togo?
- Macao, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Macao and Togo?
- 0.0%, with Macao ahead.
- How many years of comparable data are there for Macao and Togo?
- 15 years are reported by both, from 2008 to 2024.
- How do Macao and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Macao ranks 1st and Togo ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.